V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003605 | 10002286 | 1.77 | 95 | Curative (C) | null | 2018-07-27 | Bortezomib | null | N | 10483846 | BORTEZOMIB |
| 10003606 | 10002286 | 1.56 | 77.9 | Curative (C) | null | 2018-12-25 | FEC + DOCETAXEL | N | N | 10483846 | FEC + DOCETAXEL |
| 10003607 | 10002287 | 1.77 | 72.6 | Neo-adjuvant (N) | 2016-07-01 | 2016-07-04 | FEC + DOCETAXEL | null | N | 10484074 | FEC + DOCETAXEL |
| 10003608 | 10002288 | 1.76 | 71.6 | Disease modification (D) | 2018-05-14 | 2018-05-20 | PACLITAXEL | N | N | 10484098 | CHLORAMBUCIL |
| 10003609 | 10002289 | 1.68 | 61 | Curative (C) | 2017-06-12 | 2017-06-12 | Temozolomide + RT | 02 | null | 10484109 | CAPECITABINE + CISPLATIN |
| 10003610 | 10006465 | 1.65 | 83.2 | Curative (C) | 2016-09-10 | 2016-09-10 | Capecitabine 35days + RT | 02 | N | 10484131 | CAPECITABINE + RT |
| 10003611 | 10002290 | 0 | 90.6 | Curative (C) | 2016-04-26 | 2016-05-03 | CISPLATIN + RT | 02 | Y | 10484169 | CISPLATIN + RT |
| 10003612 | 10002291 | 1.65 | 88.4 | Palliative (P) | 2017-12-02 | 2017-12-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 10484201 | CAPECITABINE + CISPLATIN |
| 10003613 | 10002291 | null | null | Palliative (P) | 2013-12-22 | 2013-12-22 | Irinotecan + Modified De Gramont | N | null | 10484201 | IRINOTECAN + MDG |
| 10003614 | 10002292 | null | 71.6 | Curative (C) | 2015-06-26 | 2015-07-17 | Cisplatin + Radiotherapy | N | Y | 10484257 | CISPLATIN + RT |
| 10003615 | 10006467 | 1.61 | 57 | Adjuvant (A) | 2015-07-10 | 2015-07-15 | Fluorouracil + Folinic Acid Weekly | 02 | N | 10484317 | FLUOROURACIL |
| 10003616 | 10006467 | 1.8 | 80.9 | Adjuvant (A) | 2014-05-21 | 2014-05-21 | FEC 100 + DOCETAXEL | N | N | 10484317 | FEC + DOCETAXEL |
| 10003617 | 10002293 | 1.69 | 81.3 | Palliative (P) | 2016-04-16 | 2016-05-08 | Irinotecan + Modified De Gramont | null | N | 10484375 | IRINOTECAN + MDG |
| 10003618 | 10002294 | null | 78.1 | Neo-adjuvant (N) | null | 2018-09-21 | CAPECITABINE + RT | N | null | 10484390 | CAPECITABINE + RT |
| 10003619 | 10002294 | 1.71 | 63 | Curative (C) | 2015-03-31 | 2015-04-14 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | 10484390 | CHLORAMBUCIL |
| 10003620 | 10002295 | 1.75 | 64.6 | Adjuvant (A) | 2016-09-22 | 2016-10-01 | Fluorouracil + Folinic Acid Weekly | 02 | N | 10484421 | FLUOROURACIL |
| 10003621 | 10006469 | null | 55 | Curative (C) | 2019-05-19 | 2019-05-20 | Azacitidine | N | N | 10484424 | ABVD |
| 10003622 | 10006469 | 1.78 | 101 | Neo-adjuvant (N) | 2018-06-02 | 2018-06-11 | MaxiCHOP (Cycle 1) | 2 | N | 10484424 | EC |
| 10003623 | 10002296 | 0 | 66.9 | Adjuvant (A) | 2014-09-23 | 2014-11-04 | Chlorambucil | 02 | N | 10484468 | BORTEZOMIB |
| 10003624 | 10002297 | null | null | Palliative (P) | 2015-12-30 | 2015-12-30 | BCG Intravesical | 02 | N | 10484477 | ABIRATERONE |
| 10003625 | 10002298 | 0 | 77.4 | Adjuvant (A) | 2017-07-18 | 2017-07-21 | Fluorouricil + Folonic Acid (MdG) | N | N | 10484515 | FLUOROURACIL |
| 10003626 | 10002299 | 1.83 | 79.5 | Neo-adjuvant (N) | 2015-01-24 | 2015-01-24 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10484517 | CTD |
| 10003627 | 10002299 | 1.75 | 89 | Curative (C) | 2013-11-27 | 2013-11-29 | Imatinib 400mg | 2 | N | 10484517 | BCG |
| 10003628 | 10008112 | 1.64 | 61.8 | Curative (C) | 2018-12-09 | 2018-12-14 | Paclitaxel 7 day | N | N | 10484570 | IMATINIB |
| 10003629 | 10008112 | 1.77 | 89 | Curative (C) | 2015-07-02 | 2015-07-02 | Paclitaxel 7 day | N | N | 10484570 | CHOP |
| 10003630 | 10008112 | null | 96.2 | Palliative (P) | 2014-05-05 | 2014-05-18 | Temozolomide + RT | 02 | N | 10484570 | CTD |
| 10003631 | 10002300 | 1.61 | 83.5 | Adjuvant (A) | 2015-12-31 | 2016-01-14 | FEC + DOCETAXEL | N | null | 10484711 | FEC + DOCETAXEL |
| 10003632 | 10002301 | null | null | Curative (C) | 2018-11-15 | 2018-12-01 | IMATINIB | N | N | 10484727 | BCG |
| 10003633 | 10002302 | 1.85 | null | Adjuvant (A) | 2016-04-21 | 2016-05-01 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10484736 | FLUOROURACIL + MITOMYCIN + RT |
| 10003634 | 10002303 | 1.84 | 120 | null | 2017-08-12 | 2017-08-18 | Azacitidine | N | N | 10484757 | CISPLATIN + ETOPOSIDE |
| 10003635 | 10006471 | 1.73 | 64.2 | Adjuvant (A) | 2017-06-27 | 2017-07-05 | Cisplatin + Etoposide (3 day) | N | N | 10484808 | EC |
| 10003636 | 10006471 | 1.63 | 64 | Adjuvant (A) | null | 2018-07-09 | FLUOROURACIL | N | N | 10484808 | FLUOROURACIL |
| 10003637 | 10002304 | 1.71 | 81.45 | Palliative (P) | 2016-01-20 | 2016-01-31 | Irinotecan + Modified De Gramont | 2 | N | 10484898 | IRINOTECAN + MDG |
| 10003638 | 10002305 | null | null | Palliative (P) | null | 2017-11-06 | FLUOROURACIL + IRINOTECAN | Y | N | 10484916 | IRINOTECAN + MDG |
| 10003639 | 10002306 | 1.8 | 77.2 | Curative (C) | 2016-05-19 | 2016-05-25 | EC | N | N | 10484954 | CAPECITABINE + CISPLATIN |
| 10003640 | 10002307 | 1.68 | null | Disease modification (D) | 2017-02-26 | 2017-03-05 | CHOP - 21 days | N | N | 10484984 | BORTEZOMIB |
| 10003641 | 10002308 | 1.66 | 80 | Palliative (P) | 2013-05-06 | 2013-05-07 | Chlorambucil | 02 | N | 10485002 | BORTEZOMIB |
| 10003642 | 10002309 | 1.63 | 94 | Palliative (P) | 2017-08-18 | 2017-08-19 | Abiraterone | 2 | N | 10485020 | CHLORAMBUCIL |
| 10003643 | 10002309 | null | 0 | Palliative (P) | 2016-06-04 | 2016-06-05 | Irinotecan + Modified De Gramont | N | N | 10485020 | IRINOTECAN + MDG |
| 10003644 | 10002309 | 1.6 | 55 | Disease modification (D) | 2019-03-06 | 2019-03-21 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 10485020 | FLUOROURACIL + MITOMYCIN + RT |
| 10003645 | 10008811 | 1.77 | 78.5 | Palliative (P) | 2019-03-15 | 2019-03-24 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 10485069 | CISPLATIN + RT |
| 10003646 | 10008811 | null | 77.5 | Adjuvant (A) | 2019-01-16 | 2019-02-05 | CHOP - 21 days | N | N | 10485069 | CAPECITABINE + CISPLATIN |
| 10003647 | 10009221 | null | 57 | Unknown (U) | 2018-04-30 | 2018-04-30 | FLUOROURACIL + MITOMYCIN + RT | N | null | 10485119 | FLUOROURACIL + MITOMYCIN + RT |
| 10003648 | 10002310 | 1.72 | 105 | Curative (C) | 2015-11-28 | 2015-12-25 | Cisplatin + Radiotherapy | 02 | null | 10485121 | CISPLATIN + RT |
| 10003649 | 10002310 | 1.65 | 49.3 | Adjuvant (A) | 2015-07-18 | 2015-07-18 | Cisplatin 7 day | 02 | null | 10485121 | AZACITIDINE |
| 10003650 | 10008115 | 1.75 | 79.6 | Disease modification (D) | 2017-10-26 | 2017-11-07 | FEC + DOCETAXEL | N | N | 10485147 | FEC + DOCETAXEL |
| 10003651 | 10002311 | 1.7 | 54 | Palliative (P) | 2018-05-03 | 2018-05-12 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | 10485189 | AZACITIDINE |
| 10003652 | 10002312 | 1.75 | 70.1 | Disease modification (D) | 2016-11-20 | 2016-11-23 | Capecitabine + Cisplatin | N | N | 10485207 | CHOP |
| 10003653 | 10002313 | 1.69 | 66.2 | Curative (C) | 2018-01-13 | 2018-01-13 | BCG Intravesical | N | N | 10485288 | FLUOROURACIL + MITOMYCIN + RT |
| 10003654 | 10002314 | 1.65 | 55 | Disease modification (D) | 2016-05-28 | 2016-06-11 | Azacitidine | 2 | Y | 10485295 | PACLITAXEL |